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Summary
Introduction: Total hip replacement (THR) following hip tumor resection incurs a high risk of
dislocation. We assessed the incidence of dislocation associated with use of a dual mobility cup,
and the functional results achieved.
Hypothesis: Use of a dual mobility cup would reduce the risk of THR instability following hip
tumor resection.
Material and methods: We analyzed dislocation rates in a retrospective series of 71 dual mobil-
ity cup THRs implanted following the resection of a tumor hip condition: 33 primary bone tumors
and 38 bone metastases. The presenting pathology was diagnosed anatomically, and surgery
classiﬁed in terms of adopted abductor system strategy. Functional results were assessed in
terms of pain (analgesia on the World Health Organisation [WHO] scale), assisted walking and
Musculoskeletal Tumor Society (MSTS) score.
Results: An overall rate of 9.8% dislocation was observed, taking into account all etiolo-
gies and contexts together. More precisely, this rate resulted from a compound ﬁgure of
5.2% in bone metastasis and 15% in primitive bone tumor. Dislocation risk depended less
on etiology than on the surgical management of the abductor system, being 3.5% in the
case of abductor conservation, 9.5% in the case of abductor sectioning/reinsertion, and 18%
in case of gluteus medius muscle or nerve resection. Functional improvement was consis-
tently observed, especially in bone metastasis. At the maximal follow-up, 32 patients were
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not using analgesics, six were taking WHO class III analgesics, 10 class II and 23 class I. Mean
MSTS score was 68.1%± 23.5% in bone metastasis and 59.6%± 17.5% in primary bone tumor.
Fourteen patients could walk without assistance, 33 with a single cane, 15 with two canes and
eight with a walker; one patient had not been able to resume walking.
Discussion: In these indications, dual mobility cups use lead to lower dislocation rates than
those reported in the literature. It proved especially effective in the case of bone metastasis
and consolidation surgery. In the case of primary bone tumor, it failed to prevent dislocation
following acetabular resection, especially when involving the abductor muscles and/or abductor
innervation, although it provided lower dislocation rates, comparable to those experienced with
other techniques, when applied to limited resection.
Level of evidence: IV. Retrospective therapeutic study.
© 2009 Elsevier Masson SAS. All rights reserved.
Figure 1 Type of primitive tumor and origin of metastases.
A. Classic distribution of bone metastases according to primi-
tive tumor: breast (12 cases), lung (8 cases), kidney (6 cases),
prostate (3 cases), thyroid (2 cases), other (7 cases). B. Dis-
tribution of primitive bone tumors according to histology:
chondrosarcoma (14 cases), osteosarcoma (8 cases), Ewing sar-
coma (6 cases), rhabdomyosarcoma (2 cases), other (3 cases).
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Total hip replacement (THR) in a context of hip tumor has
a high rate of associated complications [1—3]. These mainly
comprise infections, at rates ranging from 6 to 21% accord-
ing to the study, and dislocation, at rates ranging from 0 to
41% [1—8]. These ﬁgures are much higher than the 0.6—4%
reported for THR unrelated to cancer [9].
Whatever the type of surgery and of tumor, THR in a con-
text of tumor involves multiple and sometimes associated
risk factors [10]: (a) poor anatomic restoration, especially
in case of extensive bone resection for primitive tumor;
(b) muscular insufﬁciency due to tissue and nerve resection
for the same reasons; and (c) muscle shock associated with
infectious complication, postoperative irradiation or tumor
invasion.
Dual mobility sockets, intended to reduce the incidence
of dislocation [11—13], are thus of great interest in hip tumor
surgery. We here report a descriptive retrospective study of
the incidence of dual mobility socket THR dislocation asso-
ciated with primitive or metastatic hip tumor.
Material and methods
Patients
This was a retrospective series from three centers, com-
prising 71 THRs using dual mobility sockets in indications
of hip-region tumor. There were 33 cases of primitive bone
tumor (19 males, 14 females) and 38 of bone metastasis
(14 males, 24 females). Patients were followed up until the
study date, January 1st 2007, giving a mean FU of 3.3 years
(range, 0.6—7.1 years) for the primitive bone tumors and of
1.25 years (range, 0.2—7.9 years) for the metastases. Mean
patient age was 46.3 years (range, 15—81 years) for the
primitive tumors, and 61 years (range, 34—86 years) for the
metastases. Mean preoperative body-mass index (BMI) was
23.3 for the primitive tumors, and 24.3 for the metastases.
Bone metastasis distribution according to primitive
tumor and primitive tumor histology were both clas-
sical (Fig. 1). Anatomically, femoral involvement was
classiﬁed as head/neck and/or intertrochanteric and/or
subtrochanteric, in view of the sometimes extensive
superior femoral pathology. Acetabular involvement was
classiﬁed on the modiﬁed Huntingdon system [14,15] as
T
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wrade I (segmentary defect with intact column), grade II
medial acetabular wall involvement with risk of medial
igration of the femoral head), or grade III (massive cav-
ty defect). There were several cases (10 bone metastases
nd four primitive bone tumors) of bipolar involvement asso-
iating predominant acetabular pathology with the femur.
ssociated fractures were also recorded, as was history of
urgery in the affected hip. Table 1 presents these data.
hirty-eight patients had preoperative chemotherapy and
7 preoperative local radiotherapy. Complementary treat-
ent comprised adjuvant chemotherapy for 42 patients,
ith associated local radiotherapy for 32 of these.
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Table 1 Anatomic lesion description according to bone metastasis or primitive bone tumor etiology. In 14 cases, femoral
involvement was associated with predominant acetabular lesion.
Bone metastasis
(38)
Primitive bone tumor
(33)
Femoral lesion (41)
including 14 associated
with acetabular lesions
Head/neck region 20 7
and/or Intertrochanteric region 20 10
and/or Subtrochanteric region 11 11
Total 23
(including 10
associated lesions
of the acetabulum)
18
(including 4
associated lesions of
the acetabulum)
Acetabular lesion (30) Class I 7 1
Class II 4 2
Class III 4 12
Total 15 15
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I, II or II analgesia; autonomy, in terms of assisted walking
F
rFormer surgery
Associated fracture
And/or for femoral lesion indicates the main localisation of the le
urgical techniques
egardless of etiology, surgical techniques were classiﬁed
nto 3 levels (Fig. 2):
type 1 (28 cases): consolidation surgery, involving little
resection except lesion curettage, with standard implant
reconstruction (associated to a dual mobility socket),
cementing and, usually, osteosynthesis (support ring,
plate, pin, etc.);
type 2 (21 cases): more extensive surgery, but conserving
the abductor system (conservation of gluteus medius mus-
cle and innervation, reinsertion of tendon or of greater
trochanter), whatever the extent of bone resection;
type 3 (22 cases): resection involving the gluteus medius
muscle or nerve.
The femoral component was standard for 15 patients,
ong-stemmed for 22 and a tumor reconstruction compo-
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igure 2 Classiﬁcation of surgery according to attitude to abdu
einsertion of abductor system. Type 3 (c): Resection involving glute7 6
25 6
and his dissemination to adjacent region of the proximal femur.
ent for 34. In 38 patients, the femoral component was
emented. Various dual mobility sockets were used: 29
vantageTM (Biomet, Valence, France), 19 SaturneTM (Ampli-
ude, Neyron, France), 14 NovaeTM (SERF, Décines, France),
nd nine other. Forty-one were cemented. In type-3 surgery,
5 days’ hemibermuda immobilization was generally pre-
cribed.
ssessment methods and results
wo parameters were studied pre- and postoperatively: pain
core, in terms of World Health Organisation (WHO) levelnone, one cane, two canes, frame, impossible). The Mus-
uloskeletal Tumor Society (MSTS) quality of life score [16]
as calculated postoperatively. General health status was
ssessed pre- and postoperatively by the Performance Status
core used by chemotherapy physicians (Table 2).
ctor system: Type 1 (a): Consolidation. Type 2 (b): Section-
us medius muscle or nerve.
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Table 2 General status according to the WHO Performance Status score (0 to 4). Correspondence with Karnovsky scale.
General status
Karnovsky scale World Health
Organization (WHO)
scale (1979)
Performance Status
Capacity for working
or physical activity
Intense without difﬁculty 100% 0 Normal, unrestricted outside
activity
Normal with moderate
difﬁculty
90%
Limited 80% 1 Reduction in intense physical
effort
Capacity for domestic
activity
Normal, without assistance,
but effort impossible
70% 2 No outside activity, but able
to walk >50% of time
Limited to personal needs 60% 3 Strictly personal needs;
conﬁned to bed >50% of time
Minimal with occasional
assistance
50%
Incapacity for
elementary needs
Permanent assistance 40% 4 Total incapacity; frequently
or constantly bed-ridden
Frequently bed-ridden 30%
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Results
Dislocation rate
There were seven cases (9.8%) of dislocation despite the use
of a dual mobility socket.
There were two cases of dislocation (5%) in the metasta-
sis group. One occurred at postoperative Day 7, secondary
to a fall, in a cachectic patient suffering from small-cell
lung cancer with multiple metastases, who died within the
month: a femoral metastasis without acetabular involve-
ment had been treated by consolidation surgery (type
1), with a standard cemented femoral component and
cemented dual mobility socket, without acetabular recon-
struction and with abductor conservation. The second
dislocation occurred at 5 months postoperatively, in a
patient with metastatic breast cancer; surgery had been
much more aggressive in this case, with sectioning of the
gluteus medius and its nerve and section-reinsertion of the
d
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Table 3 Dislocation rate according to type of surgery.
Type of surgery Bone met
Type I
Consolidation
25
Type II
Gluteus medius or greater trochanter tendon
reinsertion
8
Type III
Gluteus medius muscle or nerve resection
520%
10%
rochanteric medallion onto a femoral tumor reconstruction
omponent (type-3 surgery); the patient could walk with the
elp of one cane, and died three years postsurgery due to
urther metastasis. Both dislocations were reduced by exter-
al maneuver under general anesthesia, without surgical
evision.
There were ﬁve cases of dislocation (15%) in the primitive
umor group. Three (10%) were isolated, without associated
ocket loosening (‘‘isolated dislocation’’). One occurred at 1
onth postoperatively, and required surgical reduction, and
emained isolated. Another, at 3 weeks postoperatively, was
ikewise reduced by surgery, but developed associated infec-
ion. The third also occurred at 3 weeks postoperatively,
ssociated with scar disunion; all surgical samples proved
egative. Two further dislocations (5%) were associated with
ocket mobilization in dual mobility dislocation (‘‘loosening
islocation’’). Polyethylene wear required respectively
arly and late revision surgery in these two cases. Four
f the ﬁve dislocations (80%) involved Harrington grade III
rimitive acetabular bone tumor requiring large reconstruc-
astasis Primitive bone tumor Dislocation
3 1/28 (3.5%)
13 2/21 (9.5%)
17 4/22 (18.2%)
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aion following resection. The ﬁfth case was of superior
emoral involvement, which remained isolated following
xternal maneuver. Three of the ﬁve cases involved section-
ng of the gluteus medius and its nerve (type-3 surgery);
he other two involved greater trochanter sectioning
nd reinsertion onto a femoral reconstruction component
type-2 surgery).
These dislocation rates vary according to the type of
esection: 3.5% in case of abductor conservation, ver-
us 9.5% for type-2 surgery and 18% for gluteus medius
uscle or nerve resection (Table 3), i.e., dislocation
ppeared to be more frequent in case of acetabular
nvolvement and of sacriﬁce of the hip stabilization system
type-3 surgery), although the small sizes of our sub-
roups precluded any statistical demonstration of signiﬁcant
ifference.
ther postoperative complications
here were nine cases of infection: three were associated
ith bone metastasis surgery, including two remote hemato-
enic contaminations during immunodepression episodes of
hemotherapy and required surgical revision; four deep
nfections (12%), detected on bacteriology, were associated
ith primitive tumor surgery.
One case of acetabular loosening occurred 7.5 years after
one metastasis surgery in a patient in remission of can-
er, and required revision. In primitive bone tumor cases,
here were three revisions for socket loosening concerning
cetabular component mobilization with failure of Puget
econstruction for primitive pelvic bone tumor, requiring
one reconstruction revision.
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igure 3 Functional evolution of bone metastases and primitive b
nalgesia grade) (a and b), of walking (c and d), performance statusJ.-M. Philippeau et al.
unctional evolution
unctionally, postoperative pain as reported by bone metas-
asis patients was markedly improved, requiring WHO grade
II analgesia in only ﬁve cases, grade II in ﬁve and grade I in
2, with 16 patients no longer taking analgesics (Fig. 3a). In
rimitive tumor patients, preoperative pain was less intense
nd likewise showed improvement, with 16 patients no
onger taking analgesics, grade I analgesia in 11, grade II
n ﬁve and grade III in just one patient (Fig. 3b).
Seven bone metastasis patients could walk without assis-
ance postoperatively, 18 used one cane, six used two, six
sed a walking frame, and one failed to resume walking
Fig. 3c). Seven primitive tumor patients could walk with-
ut assistance postoperatively, 15 used one cane, nine used
wo, and two used a walking frame; all were able to resume
alking (Fig. 3d).
Postoperative Performance Status showed systematic
mprovement, especially in bone metastasis (Fig. 3e and f).
he mean MSTS functional score for tumor surgery recon-
truction [16] at end of follow-up in surviving patients
as 68.1%± 23.5% in case of bone metastasis (Fig. 3g) and
9.6%± 17.5% in case of primitive bone tumor (Fig. 3h).
eneral evolution
n terms of general evolution, there was deterioration in 27
f the 38 bone metastasis patients, stabilization in seven
nd remission in only four. Six were lost to follow-up,
t a mean 4.2 months (range, 7 days to 1 year). Nine-
een died, at a mean 11.1 months (1—39 months); 13
ere alive at a mean 18.3 months’ FU (3—84 months).
ixteen required surgery for metastasis in bone or other
one tumors. Pre- and postoperative assessment of pain (WHO
score, (e and f), and MSTS score (g and h).
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locations. Sixteen primitive tumor patients were in remis-
sion, 14 showed recurrence and two were stabilized. Fifteen
died, at a mean of just over 17 months (3—82 months); 17
were alive at a mean 52.1 months (16 months to 19 years).
Only one patient was lost to follow-up, at six months post-
surgery.
Discussion
The overall dislocation rate of 9.8% following dual mobil-
ity socket implantation in hip tumor surgery, whatever the
etiology and context, was relatively low compared to lit-
erature data [3,4,7,8,17—24]. Incidence varied according
to initial etiology, with 5.2% in case of bone metastasis
and 10% in case of primitive bone tumor, and according
to type of resection, with 3.5% in case of abductor sys-
tem conservation and 18% in case of gluteus medius muscle
or nerve resection. Moreover, most dislocations were early
(within the ﬁrst postoperative year), in contrast to classi-
cal reports of late dislocation associated with dual mobility
sockets [25], suggesting deﬁcient joint coaptation as a fac-
tor, whether due to resection or functional impairment of
soft parts.
The dual mobility socket was most effective in the treat-
ment of metastases, whatever the location or associated
treatment. The 5.2% dislocation rate was low compared
to literature reports [18,22,24]. We therefore consider this
prosthesis as especially indicated in this etiology, partic-
ularly as the issue of long-term implant aging associated
with dual mobility sockets is less urgent in this population
in which, despite progress in anticancer therapy, median
survival ranges from 5.6 to 19 years, depending on the
series, with 15% 5-year survivorship [3,5,21,26]. Disloca-
tion is classically more frequent in implant reconstruction
following primitive hip tumor resection [3,8,23]. Several
techniques have been suggested to limit this complica-
tion: some authors recommend bone allograft, to facilitate
muscular ﬁxation [8,27,28]; others use ‘‘ﬁbrosing’’ syn-
thetic mesh around the joint reconstruction [23,29,30];
others again use retention cups, despite their inherent
disadvantages [2,3,11,21]. We opted for dual mobility
sockets in this indication: they failed to control dislo-
cation sufﬁciently in the case of zone-2 peri-acetabular
resection, especially in the case of abductor muscle
resection or impairment; in the case of femoral tumor
resection with prosthetic reconstruction, however, they
did control dislocation as effectively as other techniques
[8,27,28].
More than etiology, it was the type of surgery which
turned out to relate to dislocation risk. And more than
the extent of femoral resection or simple consolidation
surgery, it was type-3 resection (involving the abductor
system muscles or nerves) that was associated with high dis-
location rates. The major dislocation risk factor was thus
the surgical attitude towards the hip abductor muscles,
rather than the degree of osseous involvement. Harring-
ton grade-III acetabular surgery caused less dislocation in
case of metastasis than of primitive tumor. These ﬁndings
agree with classical dislocation risk-factor data in this sub-
population, as abductor system resection is proportional
to the degree of acetabular involvement. In such indica-
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ions, even when, as was generally the case in the present
eries, a postoperative orthesis is prescribed, dual mobility
ocket reconstruction should be considered with caution and
lternative techniques should be explored. Prolonged post-
perative hemibermuda immobilization, however, appeared
o be useful.
The study conﬁrmed the effectiveness of surgery for the
evere preoperative pain associated with hip bone metas-
asis. This impact on pain and on functional impairment
oncerned even patients with short survival expectancy.
imilar beneﬁt was also observed in terms of Perfor-
ance Status. In bone metastasis, the MSTS score conﬁrmed
he general trend of our results, with patients tending
o report satisfaction. In case of primitive tumor, the
STS scores were lower, as cancer resection and large-
ubsequent scale reconstruction, while accepted by patients
s necessary, nevertheless greatly impaired functional sta-
us.
The present survivorship results agree with previous
eports [3,5,6,14]: 15% at 5 years in the case of bone metas-
asis, and 55 to 100%, depending on etiology, in case of
rimitive tumor. Even so, bone metastasis is no longer
short-term death sentence. Survivorship was especially
mproved in the present series in the case of breast metas-
ases, with patients still alive 84 months postsurgery, and
ater consulting for metastasis in other locations. These
ndings conﬁrm the interest of long-term surgical results
nd optimal general management involving multidisciplinary
ecision-making. Our primitive bone tumor results were
nfortunately in line with previous ﬁndings [17,20,26], with
nly 17 patients (53.1%) surviving more than 52 months
range, 16 months to 19 years) and 50% remission, whatever
he histology.
Patient survival can be expected to improve yet further
n the future, but implant ﬁxation and survivorship should
ot be overlooked. With this in view, we generally opted
or cemented ﬁxation with a metal-back socket. Despite
nitial doubts [31,32], Langlais et al. [33] recently reported
ncouraging results. Retrospective clinical ﬁndings, more-
ver, conﬁrmed the generally satisfactory survivorship of
ual mobility sockets [34]. Their 10-year survivorship in
oung (< 50 years) active patients, however, remains low
35,36]. Their use should therefore be reserved for patients
t high risk of instability, which is notably the case in
umoral pathology of the hip.
onclusion
he present retrospective multicenter study assembled a
arge series of dual mobility socket THRs for bone tumor.
t conﬁrmed the interest and efﬁcacy of the technique in a
athology involving a high risk of instability. Results seemed
o be better in case of metastasis around the hip, but the sur-
ical attitude towards the abductor muscles emerged as the
ajor risk factor for dislocation. In type-3 surgery resecting
he gluteus medius muscle or its innervations, dual mobility
ockets fail to ensure sufﬁcient prevention of dislocation,
nd other techniques probably need to be associated. There
lso remains the issue of long-term survival of dual mobility
ockets in young patients, whose life expectancy is likely to
e improved in the future thanks to adjuvant treatments.
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